Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000380106 | SCV000333082 | likely benign | not specified | 2015-07-24 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000946950 | SCV001093109 | likely benign | Peroxisome biogenesis disorder | 2025-01-14 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001576141 | SCV001803270 | likely benign | not provided | 2020-08-19 | criteria provided, single submitter | clinical testing | |
Mayo Clinic Laboratories, |
RCV001576141 | SCV004227237 | uncertain significance | not provided | 2022-12-01 | criteria provided, single submitter | clinical testing | BS1 |
Breakthrough Genomics, |
RCV001576141 | SCV005223801 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Prevention |
RCV004547662 | SCV004745741 | likely benign | PEX6-related disorder | 2019-12-11 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |